Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELUW) Free Cash Flow (2020 - 2025)

Historic Free Cash Flow for Celularity (CELUW) over the last 6 years, with Q3 2025 value amounting to -$4.2 million.

  • Celularity's Free Cash Flow fell 278819.44% to -$4.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.0 million, marking a year-over-year increase of 3712.01%. This contributed to the annual value of -$7.9 million for FY2024, which is 8011.48% up from last year.
  • Celularity's Free Cash Flow amounted to -$4.2 million in Q3 2025, which was down 278819.44% from -$999000.0 recorded in Q2 2025.
  • In the past 5 years, Celularity's Free Cash Flow registered a high of $164000.0 during Q4 2024, and its lowest value of -$39.3 million during Q3 2022.
  • Moreover, its 5-year median value for Free Cash Flow was -$11.3 million (2023), whereas its average is -$16.6 million.
  • In the last 5 years, Celularity's Free Cash Flow tumbled by 859212.64% in 2021 and then soared by 10353.68% in 2024.
  • Celularity's Free Cash Flow (Quarter) stood at -$34.3 million in 2021, then rose by 11.6% to -$30.4 million in 2022, then surged by 84.73% to -$4.6 million in 2023, then soared by 103.54% to $164000.0 in 2024, then tumbled by 2635.98% to -$4.2 million in 2025.
  • Its Free Cash Flow stands at -$4.2 million for Q3 2025, versus -$999000.0 for Q2 2025 and -$3.0 million for Q1 2025.